(72 days)
Not Found
No
The description focuses on the mechanical components and function of a balloon catheter, with no mention of AI, ML, image processing, or data-driven algorithms.
Yes
The device is intended to dilate stenoses in arteries, which is a therapeutic intervention to treat a medical condition.
No
The device is described as a "Balloon Dilatation Catheter" intended "to dilate stenoses," which is a therapeutic intervention, not a diagnostic one.
No
The device description clearly outlines a physical medical device (catheter with balloon, shaft, hub, etc.) and does not mention any software component as the primary or sole function.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "dilate stenoses in the femoral, popliteal, and infra-popliteal arteries." This describes a therapeutic procedure performed directly on the patient's body.
- Device Description: The description details a physical catheter designed for insertion into blood vessels to perform mechanical dilation.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo (inside the body) for a therapeutic purpose.
N/A
Intended Use / Indications for Use
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheters, with 150 mm and 210 mm balloon lengths, are intended to dilate stenoses in the femoral, popliteal, and infra-popliteal arteries.
Product codes
DQY
Device Description
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter is an over-thewire percutaneous transluminal angioplasty (PTA) catheter consisting of a proximal hub, coaxial dual lumen shaft, and a distal dilatation balloon. Hydrophilic coating covers the distal 240 mm of the catheter and radiopaque markers indicate the proximal and distal dilating surface of the balloon and facilitate placement across the stenosis. The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter is compatible with 4 F introducer catheters and 0.014" diameter guidewires. The catheter is provided with useable catheter lengths of 120 cm and 150 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
femoral, popliteal, and infra-popliteal arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench testing of the AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter demonstrated that the device could meet the bench test acceptance criteria, and was comparable to the predicate devices. Biocompatibility testing was previously performed in accordance with ISO 10993-Part 1.
Key Metrics
Not Found
Predicate Device(s)
K042624, K050073, K052791, K072947
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
MAR 13 2009
510(k) Summary
This 510(k) Summary is submitted in accordance with the requirements of 21 CFR Part 807, Section 807.92(c).
| Applicant: | Invatec S.p.A.
Via Martiri della Libertá, 7
25030 Roncadelle (Brescia) Italy
Peter Muster PhD, VP QA & RA Invatec S.p.A
Tel: +39 030 258 93 11
Fax: +39 030 258 93 12
Email: Peter.Muster@invatec.com |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Steve Camp, VP QA&RA
Invatec Inc., US
Emrick Blvd. 3101, Suite 113
Bethlehem, PA 18020
Tel: (610) 625-1402
Fax: (610) 625-1436
Email: steve.camp@invatec-us.com |
| Date Prepared: | December 30, 2008 |
Device Information
:
| Trade Name: | AMPHIRION DEEP 0.014"OTW PTA Balloon Dilatation
Catheter |
|------------------|-------------------------------------------------------------|
| Common Name: | Percutaneous Transluminal Angioplasty Catheter |
| Regulation Name: | Percutaneous Catheter |
Predicate Devices
- Invatec AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheters . (K042624, K050073 & K052791)
- Clearstream Technologies SLEEK PTA Catheter (K072947) .
Device Description
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter is an over-thewire percutaneous transluminal angioplasty (PTA) catheter consisting of a proximal hub, coaxial dual lumen shaft, and a distal dilatation balloon. Hydrophilic coating covers the distal 240 mm of the catheter and radiopaque markers indicate the proximal and distal dilating surface of the balloon and facilitate placement across the stenosis. The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter is compatible with
1
4 F introducer catheters and 0.014" diameter guidewires. The catheter is provided with useable catheter lengths of 120 cm and 150 cm.
Indication for Use
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheters, with 150 mm and 210 mm balloon lengths, are intended to dilate stenoses in the femoral, popliteal, and infra-popliteal arteries.
Technological Characteristics
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter has the same or similiar design, materials and fundamental technology as the previously cleared AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheters, and balloon lengths similar to the predicate Clearstream Technologies SLEEK PTA Catheter.
Performance Data
Bench testing of the AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter demonstrated that the device could meet the bench test acceptance criteria, and was comparable to the predicate devices. Biocompatibility testing was previously performed in accordance with ISO 10993-Part 1.
Conclusion
Based on similar intended use, technological characteristics, and performance characteristics, the AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter is substantially equivalent to the predicate devices.
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the eagle. The eagle is black, and the text is also black. The background is white.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 1 3 2009
Invatec. Inc. c/o Mr. Steve Camp Vice President, Clinical and Regulatory Affairs 3101 Emrick Boulevard, Suite 113 Bethlehem, PA 18020
K083919 Re:
Trade/Device Name: AMPHIRON DEEP 0.014" PTA Balloon Dilatation Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II (two) Product Code: DQY Dated: December 30, 2008 Received: December 31, 2008
Dear Mr. Camp:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for ass surfall to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, devices that have been rout do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of general obtarely provision practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device it may be subject to bach of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA can or found in ther announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Steve Camp
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
er D. Vachner
$\delta_v$
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
4
Indications for Use
510(k) Number (if known): K083919
Device Name: AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheter
Indications for Use:
The AMPHIRION DEEP 0.014" OTW PTA Balloon Dilatation Catheters, with 150 mm and 210 mm balloon lengths, are intended to dilate stenoses in the femoral, popliteal, and infra-popliteal arteries.
× Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Dummer 2. Volunt
Page 1 of 1
Division Cinn. a novascular Devices A *** ****
510(K) Number_Ko8391 9
ii